Intervention

The effect of methanolic extract of hyoscyamus niger containing steroidal glycosides with propolis in patients with acute respiratory infection (infection or suspected covid-19): A clinical trials

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

IRCT

Registry ID

IRCT20200516047462N1

Enrollment

Registered

2020-05-17

Start date

2020-05-06

Completion date

Unknown

Last updated

2020-06-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

covid 19. Covid-19

Interventions

Intervention 1: Intervention group: Products containing 10 mg of methanolic extract plus 450 mg of propolis will be prescribed three times a day for each patient. This amount of active ingredients is

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: The patient must have a voluntary consent to participate in operation; The patient's clinical symptoms such as: dry cough, shortness of breath, fever, shortness of breath, fatigue, etc. in suspected or associated with COVID-19 is evaluated after treatment and these symptoms are compared with placebo group.

Exclusion criteria

Exclusion criteria: Heart patients, mental patients and pregnant women

Design outcomes

Primary

Measure	Time frame
Shortness of breath, medicine, dry cough, chills and etc. Timepoint: May and June. Method of measurement: Quantitative and qualitative.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactMorteza Kosari

Kashan University of Medical Sciences

kosarimorteza12@gmail.com+98 31 5434 6622

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026